GLYCOREX TRANSPLANTATION
Glycorex Transplantation AB (publ) is a medical technology company that conducts research, development, production and sales, especially in the field of organ transplantation. The company's main product, Glycosorb ยฎ -ABO, enables transplants across the blood group boundaries. This product has been used clinically since the fall of 2001 and enabled more than 3,500 blood group incompatible transplants with excellent clinical results. The company also develops products within universal blood plasma and products for specific treatment of autoimmune diseases, specifically Myasthenia gravis.
GLYCOREX TRANSPLANTATION
Industry:
Biotechnology Clinical Trials Health Care Manufacturing Medical Pharmaceutical
Founded:
1996-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.glycorex.se
Total Employee:
11+
Status:
Active
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Cision
Similar Organizations
Body Surface Translations
Body Surface Translations is a biomedical device company.
Promedim
Promedim is advanced cloud-based technology, integrated control centre.
Current Employees Featured
Founder
Official Site Inspections
http://www.glycorex.se
- Host name: akilles.oderland.com
- IP address: 91.201.60.23
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Glycorex Transplantation"
Board of Directors and CEO - Glycorex Transplantation โฆ
Mar 29, 2021 Background and education: Founder and former CEO and Development and Product Manager at Glycorex Transplantation AB. Currently โฆSee details»
Contact - Glycorex Transplantation AB
Mar 29, 2021 +46 46 286 52 30 [email protected]. About Glycorex. Market strategy; Investors. Financial reports; The Share โ information; Presentations; Corporate Governance; Board of โฆSee details»
Glycorex Transplantation - Crunchbase Company โฆ
Glycorex Transplantation AB (publ) is a medical technology company that conducts research, development, production and sales, especially in the field of organ transplantation. The company's main product, Glycosorb ® -ABO, โฆSee details»
Glycorex Transplantation AB (publ) | LinkedIn - LinkedIn Sverige
Glycorex Transplantation AB (publ) | 970 följare på LinkedIn. Optimizing blood for life โ solutions for improved quality of life and better health economy | Glycorex Transplantation AB (publ) is a โฆSee details»
Glycorex AB - A Company At Ideon - Ideon Science Park
Glycorex AB. Address. Scheelevägen 27, 223 70 Lund. Building. Gateway. Company website. www.glycorex.se. Phone. 046-286 5230. E-mail. [email protected]. About Ideon. โฆSee details»
Glycorex Transplantation AB | Ideon Science Park
Glycorex Transplantation AB (publ) is a medical technology company involved in development, production and sales in the fields of organ transplantation and ...See details»
Glycorex Transplantation AB | Nordic Growth Market - ngm.se
Glycorex Transplantation is a biotechnology company. Currently, the company conducts research, development and marketing within the field of organ transplantation. The main product of the โฆSee details»
Glycorex Transplantation Company Profile - Office Locations ...
Glycorex Transplantation kr36.12 m in annual revenue in FY 2022. See insights on Glycorex Transplantation including office locations, competitors, revenue, financials, executives, โฆSee details»
About Glycorex - Glycorex Transplantation AB
Glycorex has recently launched a new product version designed to be used for donated plasma to produce universal blood plasma that can be given regardless of the recipientโs blood group, โฆSee details»
Glycorex strengthens the organization to place additional force โฆ
Jan 31, 2023 On December 8, 2022, Johan Lavén took over as the new CEO of Glycorex with the task of implementing the company's growth strategy by expanding the company's โฆSee details»
Glycorex Transplantation - placera.se
Dec 21, 2021 E-mail: [email protected], phone: 046-286 52 30 Brief information about the company Glycosorb® ABO is one of Glycorex Transplantation AB's self-developed proprietary โฆSee details»
Glycorex Transplantation - placera.se
Nov 2, 2021 Johan Nilsson, Interim CEO, Glycorex Transplantation AB. E-mail: [email protected], phone: 046-286 52 30. This information is such information that Glycorex โฆSee details»
Glycorex strengthens the organization to place additional force โฆ
The organization is now fully focused on delivering on our Going 4 Growth strategy that holds great growth opportunities in a number of areas, short-term as well as long-term. To add โฆSee details»
Glycorex Transplantation
Mar 9, 2023 Johan Lavén, CEO Glycorex Transplantation AB Email: [email protected] Tel: + 46 (0)73 330 92 16. Brief information about the company. Glycorex Transplantation AB โฆSee details»
Enabling transplants across blood groups is no longer science fiction
CEO Geert Nygaard joined Glycorex in December 2021. Since then, he has worked together with his team to define the way forward for the company. In this interview, Geert talks about โฆSee details»
Glycorex Transplantation: Manufacturing of low titer-blood
Glycorex Transplantation AB (publ.), listed on NGM Main Regulated Equity, announces that the Transfusion unit at the University of Rochester Medical Center presents their experience with โฆSee details»
Financial reports - Glycorex Transplantation AB
+46 46 286 52 30 [email protected]. About Glycorex. Market strategy; Investors. Financial reports; The Share โ information; Presentations; Corporate Governance; Board of Directors โฆSee details»
Glycorex ökar omsättningen och minskar förlusten - Dagens industri
3 days ago Medicinteknikbolaget Glycorex hade ett rörelseresultat om -3,0 miljoner kronor under det tredje kvartalet (-5,4). Nettoomsättningen uppgick till 7,4 miljoner kronor (6,2). ... org.nr: โฆSee details»
Glycorex strengthens the organization to place additional force โฆ
Jan 31, 2023 On December 8, 2022, Johan Lavén took over as the new CEO of Glycorex with the task of implementing the company's growth strategy by expanding the company's โฆSee details»